Literature DB >> 10425030

Monitoring of zonisamide in human breast milk and maternal plasma by solid-phase extraction HPLC method.

R Shimoyama1, T Ohkubo, K Sugawara.   

Abstract

An HPLC method was developed for the determination of zonisamide in human breast milk and plasma. Chromatographic separation was achieved using a Develosil CN analytical column with potassium dihydrogenphosphate buffer (pH 3.5 with milk, pH 2.5 with plasma)-acetonitrile as the mobile phase. Zonisamide and 1, 2-benzisoxazole-3-methansulfonamine acetate as internal standard were detected by ultraviolet absorbance at 240 nm. Zonisamide in breast milk and plasma was extracted by a rapid and simple procedure based on C(18) bonded-phase extraction. Determination of zonisamide in human breast milk and plasma was possible in the concentration range 0.05-20.0 microg/mL. The recoveries of zonisamide added to human breast milk and plasma were 79.5-85.0% and 86.3-93.1%, respectively, with coefficients of variation of less than 8.3% and 11.4% respectively. The mean concentrations of zonisamide in breast milk and plasma were 9.41 +/- 0.95 and 10.13 +/- 0.45 microg/mL, respectively. The average ratio between the breast milk concentration and plasma concentration (M/P ratio) was 0.93 +/- 0.09. Copyright 1999 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425030     DOI: 10.1002/(SICI)1099-0801(199908)13:5<370::AID-BMC900>3.0.CO;2-5

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  11 in total

Review 1.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

2.  Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.

Authors:  Juseop Kang; Yoo-Sin Park; Shin-Hee Kim; Sang-Hyun Kim; Min-Young Jun
Journal:  Korean J Physiol Pharmacol       Date:  2011-04-30       Impact factor: 2.016

3.  Simultaneous determination of lamotrigine, zonisamide, and carbamazepine in human plasma by high-performance liquid chromatography.

Authors:  Elizabeth Greiner-Sosanko; Darla R Lower; Mohamed A Virji; Matthew D Krasowski
Journal:  Biomed Chromatogr       Date:  2007-03       Impact factor: 1.902

Review 4.  Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide.

Authors:  Bruna Nucera; Francesco Brigo; Eugen Trinka; Gudrun Kalss
Journal:  Ther Adv Neurol Disord       Date:  2022-06-11       Impact factor: 6.430

5.  Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC-UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam.

Authors:  Elizabeth Greiner-Sosanko; Spiros Giannoutsos; Darla R Lower; Mohamed A Virji; Matthew D Krasowski
Journal:  J Chromatogr Sci       Date:  2007-10       Impact factor: 1.618

Review 6.  Management of epilepsy during pregnancy.

Authors:  Dina Battino; Torbjörn Tomson
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  [Use of antiepileptic drugs during breastfeeding : What do we tell the mother?]

Authors:  M Crettenand; A O Rossetti; T Buclin; U Winterfeld
Journal:  Nervenarzt       Date:  2018-08       Impact factor: 1.214

8.  Use of common migraine treatments in breast-feeding women: a summary of recommendations.

Authors:  Susan Hutchinson; Michael J Marmura; Anne Calhoun; Sylvia Lucas; Stephen Silberstein; B Lee Peterlin
Journal:  Headache       Date:  2013-03-06       Impact factor: 5.887

9.  Rapid and sensitive high performance liquid chromatographic determination of zonisamide in human serum application to a pharmacokinetic study.

Authors:  M B Majnooni; B Mohammadi; R Jalili; G H Bahrami
Journal:  Indian J Pharm Sci       Date:  2012-07       Impact factor: 0.975

10.  Antiepileptic drugs and breastfeeding.

Authors:  Riccardo Davanzo; Sara Dal Bo; Jenny Bua; Marco Copertino; Elisa Zanelli; Lorenza Matarazzo
Journal:  Ital J Pediatr       Date:  2013-08-28       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.